Table 2.
CD3+ | CD3−CD56+ | |||
---|---|---|---|---|
% | MFI | % | MFI | |
CD94 | ||||
Controls | 10 | 100 | 93 | 80 |
(n = 6) | ||||
Patient | 19 | 66 | 83 | 232 |
CD94/NKG2A | ||||
Controls (n = 6) | 7 | 145 | 44 | 97 |
(n = 6) | ||||
Patient | 8 | 118 | 69 | 267 |
ILT2 | ||||
Controls | 15 | 35 | 19 | 36 |
(n = 6) | ||||
Patient | 31 | 36 | 48 | 106 |
The results are expressed as mean fluorescence intensity (MFI) and percentage of positive cells.